论文部分内容阅读
我们自1978年7月起,应用中国医学科学院药物研究所提供的靛玉红片治疗慢粒以及其他骨髓增生性疾病42例。现就其疗效及有关问题总结如下: 一、一般资料 42例中。慢粒24例,其余18例包括骨髓纤维化、真性红细胞增多症(以下简称真红)、慢性淋巴细胞型白血病(以下简称慢淋)、慢粒急变、红白血病、亚急性粒细胞
We since July 1978, the application of Chinese Academy of Medical Sciences Institute of indirubin provided tablets and other myeloproliferative diseases in 42 cases. Now on its efficacy and related issues are summarized as follows: First, the general information in 42 cases. 24 cases of CML, the remaining 18 cases, including myelofibrosis, polycythemia vera (hereinafter referred to as true red), chronic lymphocytic leukemia (hereinafter referred to as CLL), CML, erythroleukemia, subacute granulocytes